Oslo Cancer Cluster is a non-profit member organization dedicated to accelerate the development of new cancer diagnostics and medicines.

We will achieve this through:

• Local collaboration and international partnership.
• Increasing our member companies’ ability to attract capital.
• Creating an efficient clinical trials network to shorten development timelines.
• Building Oslo Cancer Cluster Innovation Park bridging research, biopharma and education.

Oslo Cancer Cluster were established in 2006, and have more than 60 members from all over Scandinavia. Our members comprise of small biotechnology companies, large pharmaceutical companies, university hospitals, bio banks and registries, technology transfer offices, academic research institutions and patient groups.

Together the members work to fulfil Oslo Cancer Clusters vision: «We are committed to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.»

One in three will be diagnosed with cancer during life and it is crucial to develop new diagnostics and medication.